PharmacoEconomics

Warfarin Pharmacogenetics: Economic Considerations
pp. 899-902(4)
Authors: Hughes, Dyfrig A.; Pirmohamed, Munir

It's Time to Choose the Study Design!: Net Benefit Analysis of Alternative Study Designs to Acquire Information for Evaluation of Health Technologies
pp. 903-911(9)
Authors: Shavit, Oren; Leshno, Moshe; Goldberger, Assaf; Shmueli, Amir; Hoffman, Amnon

The Cost Effectiveness of Bisphosphonates for the Prevention and Treatment of Osteoporosis: A Structured Review of the Literature
pp. 913-933(21)
Authors: Fleurence, Rachael L.; Iglesias, Cynthia P.; Johnson, Jeanene M.

Economic Evaluations of Calcineurin Inhibitors in Renal Transplantation: A Literature Review
pp. 935-947(13)
Authors: Miners, Alec H.; Yao, Guiqing; Raftery, James; Taylor, Rod S.

Strategies for the Management of Suspected Heparin-Induced Thrombocytopenia: A Cost-Effectiveness Analysis
pp. 949-961(13)
Authors: Patrick, Amanda R.; Winkelmayer, Wolfgang C.; Avorn, Jerry; Fischer, Michael A.

Cost Effectiveness of Entecavir versus Lamivudine with Adefovir Salvage in HBeAg-Positive Chronic Hepatitis B
pp. 963-977(15)
Authors: Veenstra, David L.; Sullivan, Sean D.; Clarke, Lauren; Iloeje, Uche H.; Tafesse, Eskinder; Adrian Di Bisceglie,; Kowdley, Kris V.; Gish, Robert G.

The Economic Impact of Introducing Serotonin-Noradrenaline Reuptake Inhibitors into the Brazilian National Drug Formulary: Cost-Effectiveness and Budget-Impact Analyses
pp. 979-990(12)
Authors: Machado, Márcio; Iskedjian, Michael; Ruiz, Inés A.; Einarson, Thomas R.